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Background: We describe a case and review ten other instances of group B streptococcal endocarditis in the
setting of obstetric and gynecologic practice reported since the last review in 1985.
Case: Abortionremainsacommonantecedentevent,butincontrasttoearlierreports,mostpatientsdidnothave
underlying valvular disease, the tricuspid valve was most often involved, and mortality was low. Patients with
tricuspidvalveinfectiontendedtohaveasubacutecourse,whereasthosewithaorticormitralinvolvementtypically
had a more acute, fulminant course.
Conclusion: Despite an improvement in mortality, morbidity remains high, with 8 of 11 patients having clinically
significant emboli.
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Streptococcus agalactiae, better known as group B
streptococcus (GBS), is a common cause of
neonatal sepsis and meningitis. The organism is
acquired by the neonate from the vaginal flora of
the mother at the time of parturition. In adults, the
epidemiology of GBS infections has changed from
an uncommon cause of puerperal sepsis in the
pre-antibiotic era to that of an infrequent, but
important etiology of bacteremia and locally
invasive infections in diabetics, alcoholics and
others with chronic debilitating diseases1–4.
Although GBS is an uncommon cause of
endocarditis when all etiologies are considered,
endocarditis accounts for 10% of reported inva-
sive infections due to this organism4–7.
We here report a case of GBS prosthetic valve
endocarditis associated with an obstetrical
procedure, and we review cases of GBS
endocarditis in obstetric and gynecologic practice
reported in the English-language literature since
1985, the time of the last review of this subject8.
METHODS
A computerized, English-language literature
search via the Medline database was performed
for reported cases of infective endocarditis caused
by GBS that were associated with obstetric or
gynecologic conditions and/or procedures. The
searchwasrestrictedtotheperiodbetweenJanuary
1985 and June 2002. The following key words
were used in the search: ‘endocarditis’, ‘group B
streptococcus’, ‘Streptococcus agalactiae’, ‘preg-
nancy’, ‘abortion’, ‘obstetric’ and ‘gynecology’.
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A 37-year-old woman with a history of infective
endocarditis 11 years earlier that necessitated
replacement of both aortic and mitral valves
came to the emergency department with com-
plaints of fever, chills, shortness of breath and
left-sided pleuritic pain of 4 days’ duration. Six
months before her acute illness, while she was
8 weeks pregnant, she was hospitalized for a near
syncopal episode and was found to have critical
aortic stenosis. An uneventful elective abortion
was performed due to concerns about further
hemodynamic complications during pregnancy.
The patient received 2 g of ampicillin and 100 mg
of gentamicin intravenously prior to the dilation
and curettage, followed by 1g of ampicillin intra -
venously 6 hours later. Surgery to repair the aortic
stenosiswasrecommended,butthepatientrefused
this. Approximately 2 months after the abortion,
she presented to the gynecology clinic complain-
ing of heavy vaginal bleeding and pelvic pain. The
physical examination was unremarkable and a
Papanicolaou cervical smear was performed.
The patient received a course of oral medroxy-
progesterone and had initial resolution of
menorrhagia. Approximately 1month prior to
her admission she presented again to her gyne-
cologist with a 2-week history of recurrent
vaginal bleeding and pelvic pain. Another course
of medroxyprogesterone was prescribed.
The patient had a history of intravenous drug
use, but had quit 18 months prior to her presenta-
tion. She had snorted cocaine 2 days before her
admission. Apart from the elective abortion she
denied any surgical procedure or dental work
during the months preceding her illness.
The physical examination that was performed
on admission revealed a well-developed, pale
woman who was very anxious about her illness.
Her temperature was 39.7°C; heart rate was 120
beats/minute; blood pressure was 100/66 mmHg
and respiration rate was 24 breaths/minute. A
3/6 early systolic ejection murmur was heard at
the base of the heart radiating to the apex. No
stigmata of infective endocarditis were present.
A chest X-ray revealed no abnormalities, and
the electrocardiogram showed sinus tachycardia.
The patient’s white blood cell count was
5600 cells/mm3 with 80% neutrophils, 2% bands,
7% lymphocytes and 11% monocytes. She was not
anemic. Her serum sodium concentration was
127 mmol/l (normal range 135–145 mmol/l),
potassium concentration was 2.9 mmol/l
(normal range 3.5–5.0 mmol/l) and phosphorus
concentration was 2.2 mg/dl (normal range
2.5–4.5 mg/dl).Aurinedrugscreenwasnegative.
The patient was given vancomycin, gentamicin
and rifampin for suspected infective endocarditis.
Two blood cultures from the day of admission
grew Streptococcus agalactiae (group B strepto-
coccus), and the antibiotic regimen was changed
to ampicillin 2 g every 6 hours and gentamicin
100 mg every 8 hours, both administered intra-
venously. A transthoracic echocardiogram
revealed a vegetation on the outflow side of the
prosthetic aortic valve (Figure 1) and a possible
vegetation on the left ventricular side of the
prosthetic mitral valve. The area of the aortic
valve was 0.8 cm2.
During the hospital course, the patient
developed worsening of her left lower chest
pleuritic pain and a new finding of tender
splenomegaly. Tender nodules on her fingers
consistent with Osler’s nodes were also found, and
she complained of pain in the anterior aspect of
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Figure 1 Transthoracic echocardiogram from a
patient with group B streptococcal endocarditis demon-
strating a vegetation on the outflow side of her
prosthetic aortic valveboth lower extremities. Follow-up chest X-rays
showed left lower lobe atelectasis with a small
pleural effusion, and computed tomography
showed multiple hypodense, peripheral, wedge-
shaped areas in the spleen consistent with septic
emboli (Figure 2). Subsequent blood cultures
throughoutherhospitalizationshowednogrowth,
and after 10 days of antimicrobial treatment she
became afebrile.
Initially, replacement of the aortic and mitral
valves was planned, but the patient refused to
undergo surgery. It was decided to follow her
clinical course closely and intervene if signs of
heart failure developed. A transesophageal echo-
cardiogram taken 3 weeks after admission showed
no apparent vegetations and an improved aortic
valve area of 1.1 cm2. The patient’s clinical
condition improved, and she completed 6 weeks
of antimicrobial therapy. She was last seen 10
months after hospitalization, and has remained
asymptomatic.
DISCUSSION
In women of childbearing age, colonization of
thegenitaltractwithGBSiscommonandservesas
a reservoir for a variety of infections, including
maternal endometritis and bacteremia as well as
neonatal sepsis and meningitis1. Despite this,
infective endocarditis in obstetric and gynecologic
practiceisrare.SeaworthandDurack7reviewed99
casesofall-causeendocarditisintheobstetricaland
gynecological literature from 1940 to 1983. There
were only seven cases caused by GBS, but GBS
accountedfor16%ofthecasesfollowingabortion.
Pregnancy-associated GBS endocarditis was
reviewed in 1985 by Sexton et al.8, who reported
two new cases and collected 19 more cases from
the literature, including cases from both the pre-
and post-antibiotic era. Most of the patients had
pre-existing valvular heart disease. Prior to the
advent of antimicrobial therapy, almost all cases
involvedthemitralvalve,butinthepost-antibiotic
era the tricuspid and aortic valves were involved as
oftenasthemitralvalve.Anacutecourse,similarto
that seen in staphylococcal endocarditis and in
contrast to the more subacute course of viridans
streptococcal disease, was the norm. A high rate of
complications was also observed – both index
cases developed annular abscesses and had a fatal
outcome. A decrease in mortality from 67% to
43% was observed after the advent of antibiotics.
Including our report, 11 cases of GBS endo-
carditis have been published in the English-
language literature since 1985 (Table 1). The
majority of patients (64%) did not have a pre-
disposing valvular condition. The exceptions
were one instance of mitral valve prolapse with
regurgitation10, one patient with rheumatic mitral
valve disease17 and two patients with mechanical
valves17, one of whom is our patient who under-
went bivalvular replacement surgery several years
priortoherpresentation.Since1985,incontrastto
earlier reports, the tricuspid valve was the most
commonly involved valve (6 of 11 cases), the
course was subacute rather than fulminant, and
valve replacement was required in only four
patients. In patients with non-tricuspid valve
involvement, the clinical course was typically
more aggressive, resembling that of staphylococcal
endocarditis. What is even more interesting is that
only one patient died (mortality rate of 9%), a
dramatic decrease from the mortality rate of
around 40–70% noted in earlier series2,6,8,18.A
low mortality rate (12.9%) was also found in a
review of all β-hemolytic streptococcal endo-
carditis; GBS was the most common isolate. A
recently published review17 of 30 cases of GBS
Group B streptococcal endocarditis Crespo et al.
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Figure 2 Computed tomography image of the
abdomen from a patient with group B streptococcal
endocarditis demonstrating multiple, hypodense,
wedge-shaped densities in the spleen consistent with
septic emboliGroup B streptococcal endocarditis Crespo et al.
112 • INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY
C
a
s
e
n
u
m
b
e
r
A
g
e
(
y
e
a
r
s
)
O
b
s
t
e
t
r
i
c
/
g
y
n
e
c
o
l
o
g
i
c
a
l
c
o
n
d
i
t
i
o
n
o
r
p
r
o
c
e
d
u
r
e
i
n
v
o
l
v
e
d
U
n
d
e
r
l
y
i
n
g
h
e
a
r
t
v
a
l
v
e
d
i
s
e
a
s
e
V
a
l
v
e
D
u
r
a
t
i
o
n
o
f
s
y
m
p
t
o
m
s
b
e
f
o
r
e
d
i
a
g
n
o
s
i
s
H
e
a
r
t
v
a
l
v
e
r
e
p
l
a
c
e
d
O
u
t
c
o
m
e
C
o
m
p
l
i
c
a
t
i
o
n
s
T
h
e
r
a
p
y
Y
e
a
r
a
n
d
r
e
f
e
r
e
n
c
e
1
1
8
P
r
e
m
a
t
u
r
e
r
u
p
t
u
r
e
o
f
m
e
m
b
r
a
n
e
s
N
o
n
e
A
o
r
t
i
c
3
d
a
y
s
N
o
C
u
r
e
d
N
o
n
e
P
e
n
i
c
i
l
l
i
n
G
,
2
0
m
i
l
l
i
o
n
u
n
i
t
s
/
d
a
y
f
o
r
2
8
d
a
y
s
,
p
l
u
s
g
e
n
t
a
m
i
c
i
n
,
1
8
0
m
g
/
d
a
y
f
o
r
1
4
d
a
y
s
1
9
8
5
9
2
3
0
V
a
g
i
n
a
l
d
e
l
i
v
e
r
y
M
i
t
r
a
l
v
a
l
v
e
p
r
o
l
a
p
s
e
w
i
t
h
r
e
g
u
r
g
i
t
a
t
i
o
n
M
i
t
r
a
l
4
w
e
e
k
s
N
o
C
u
r
e
d
A
m
a
u
r
o
s
i
s
f
u
g
a
x
P
e
n
i
c
i
l
l
i
n
G
,
1
6
m
i
l
l
i
o
n
u
n
i
t
s
/
d
a
y
f
o
r
4
5
d
a
y
s
,
p
l
u
s
g
e
n
t
a
m
i
c
i
n
2
4
0
m
g
/
d
a
y
f
o
r
2
d
a
y
s
1
9
8
7
1
0
3
1
8
E
l
e
c
t
i
v
e
a
b
o
r
t
i
o
n
N
o
n
e
T
r
i
c
u
s
p
i
d
S
e
v
e
r
a
l
w
e
e
k
s
N
o
C
u
r
e
d
S
e
p
t
i
c
p
u
l
m
o
n
a
r
y
e
m
b
o
l
i
P
e
n
i
c
i
l
l
i
n
G
,
2
4
m
i
l
l
i
o
n
u
n
i
t
s
/
d
a
y
,
p
l
u
s
g
e
n
t
a
m
i
c
i
n
,
1
8
0
m
g
/
d
a
y
f
o
r
6
w
e
e
k
s
1
9
9
0
1
1
4
3
0
E
l
e
c
t
i
v
e
a
b
o
r
t
i
o
n
N
o
n
e
T
r
i
c
u
s
p
i
d
4
w
e
e
k
s
Y
e
s
C
u
r
e
d
S
e
p
t
i
c
p
u
l
m
o
n
a
r
y
e
m
b
o
l
i
,
f
i
r
s
t
-
d
e
g
r
e
e
h
e
a
r
t
b
l
o
c
k
V
a
n
c
o
m
y
c
i
n
f
o
r
2
8
d
a
y
s
1
9
9
1
1
2
5
3
6
P
a
p
a
n
i
c
o
l
a
o
u
c
e
r
v
i
c
a
l
s
m
e
a
r
N
o
n
e
T
r
i
c
u
s
p
i
d
7
d
a
y
s
Y
e
s
C
u
r
e
d
S
e
v
e
r
e
t
r
i
c
u
s
p
i
d
r
e
g
u
r
g
i
t
a
t
i
o
n
P
e
n
i
c
i
l
l
i
n
p
l
u
s
g
e
n
t
a
m
i
c
i
n
f
o
r
3
w
e
e
k
s
b
e
f
o
r
e
T
V
R
f
o
l
l
o
w
e
d
b
y
a
m
p
i
c
i
l
l
i
n
p
l
u
s
g
e
n
t
a
m
i
c
i
n
f
o
r
6
w
e
e
k
s
1
9
9
7
1
3
6
3
3
E
l
e
c
t
i
v
e
a
b
o
r
t
i
o
n
N
o
n
e
T
r
i
c
u
s
p
i
d
4
w
e
e
k
s
Y
e
s
C
u
r
e
d
S
e
p
t
i
c
p
u
l
m
o
n
a
r
y
e
m
b
o
l
i
,
v
a
l
v
e
r
i
n
g
a
b
s
c
e
s
s
P
e
n
i
c
i
l
l
i
n
p
l
u
s
g
e
n
t
a
m
i
c
i
n
f
o
r
6
w
e
e
k
s
1
9
9
8
1
4
7
2
4
E
l
e
c
t
i
v
e
a
b
o
r
t
i
o
n
N
o
n
e
T
r
i
c
u
s
p
i
d
4
w
e
e
k
s
N
o
C
u
r
e
d
S
e
p
t
i
c
p
u
l
m
o
n
a
r
y
e
m
b
o
l
i
,
r
i
g
h
t
-
s
i
d
e
d
h
e
a
r
t
f
a
i
l
u
r
e
A
m
p
i
c
i
l
l
i
n
p
l
u
s
g
e
n
t
a
m
i
c
i
n
f
o
r
6
w
e
e
k
s
2
0
0
0
1
5
C
o
n
t
i
n
u
e
d
T
a
b
l
e
1
C
a
s
e
s
o
f
g
r
o
u
p
B
s
t
r
e
p
t
o
c
o
c
c
a
l
e
n
d
o
c
a
r
d
i
t
i
s
i
n
o
b
s
t
e
t
r
i
c
s
a
n
d
g
y
n
e
c
o
l
o
g
y
s
i
n
c
e
1
9
8
5Group B streptococcal endocarditis Crespo et al.
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY • 113
8
6
0
G
i
a
n
t
p
y
o
m
y
o
m
a
N
o
n
e
T
r
i
c
u
s
p
i
d
1
2
w
e
e
k
s
N
o
C
u
r
e
d
N
o
n
e
P
e
n
i
c
i
l
l
i
n
G
,
1
8
m
i
l
l
i
o
n
u
n
i
t
s
/
d
a
y
,
p
l
u
s
a
m
i
k
a
c
i
n
6
0
0
m
g
/
d
a
y
a
d
d
e
d
o
n
d
a
y
1
1
(
u
n
k
n
o
w
n
d
u
r
a
t
i
o
n
)
2
0
0
1
1
6
9
4
2
G
e
n
i
t
a
l
i
n
f
e
c
t
i
o
n
R
h
e
u
m
a
t
i
c
v
a
l
v
e
d
i
s
e
a
s
e
M
i
t
r
a
l
1
0
d
a
y
s
N
o
C
u
r
e
d
N
o
n
e
P
e
n
i
c
i
l
l
i
n
G
p
l
u
s
g
e
n
t
a
m
i
c
i
n
2
0
0
2
1
7
1
0
3
2
G
e
n
i
t
a
l
i
n
f
e
c
t
i
o
n
P
r
o
s
t
h
e
t
i
c
m
i
t
r
a
l
v
a
l
v
e
M
i
t
r
a
l
5
d
a
y
s
Y
e
s
D
i
e
d
S
t
r
o
k
e
P
e
n
i
c
i
l
l
i
n
G
p
l
u
s
g
e
n
t
a
m
i
c
i
n
2
0
0
2
1
7
1
1
3
7
E
l
e
c
t
i
v
e
a
b
o
r
t
i
o
n
,
P
a
p
a
n
i
c
o
l
a
o
u
c
e
r
v
i
c
a
l
s
m
e
a
r
,
v
a
g
i
n
a
l
b
l
e
e
d
i
n
g
P
r
o
s
t
h
e
t
i
c
a
o
r
t
i
c
a
n
d
m
i
t
r
a
l
v
a
l
v
e
s
A
o
r
t
i
c
a
n
d
p
o
s
s
i
b
l
e
m
i
t
r
a
l
v
a
l
v
e
4
d
a
y
s
N
o
C
u
r
e
d
L
e
f
t
-
s
i
d
e
d
p
l
e
u
r
i
s
y
,
s
e
p
t
i
c
s
p
l
e
n
i
c
e
m
b
o
l
i
,
e
m
b
o
l
i
t
o
e
x
t
r
e
m
i
t
i
e
s
A
m
p
i
c
i
l
l
i
n
8
g
/
d
a
y
,
p
l
u
s
g
e
n
t
a
m
i
c
i
n
,
3
0
0
m
g
/
d
a
y
,
f
o
r
6
w
e
e
k
s
2
0
0
2
P
r
e
s
e
n
t
c
a
s
e
T
V
R
,
t
r
i
c
u
s
p
i
d
v
a
l
v
e
r
e
p
l
a
c
e
m
e
n
t
T
a
b
l
e
1
c
o
n
t
i
n
u
e
dendocarditis since 1980 found a similar trend
towards lower mortality rate (21%) compared
with earlier cases. In this review, all patients with
prosthetic valve endocarditis died (five cases).
The reason for this markedly improved outcome
is not obvious, and it is not explained by changes
in antimicrobial therapy or surgical technique.
Prompt use of blood cultures in febrile patients
and the more frequent use of echocardiography
might account for earlier diagnosis, earlier surgical
intervention when necessary, and improved
survival, but this is only speculation. Other
factors that might be associated with a favorable
outcome in this group include young age and
tricuspid rather than aortic or mitral involvement.
Despite the improvement in mortality rate, the
morbidity rate remains high, with 8 of 11 patients
having clinically significant emboli.
With regard to the obstetric or gynecologic
conditions or procedures that preceded the
development of endocarditis, abortion continued
to be most commonly implicated. A report of
one case following a Papanicolaou cervical smear13
suggests that even simple, minimally invasive pro-
cedures can serve to introduce bacteria into the
bloodstream. One patient with an infected uterine
leiomyoma presented with tricuspid valve endo-
carditis and had not had any intervention prior
to her admission to hospital16. The only case
following a vaginal delivery was in a woman
with known valvular heart disease10. None of
the patients in this report were active intravenous
drug users.
Thepathogenesisofinfectioninthepresentcase
is unclear. The patient had a therapeutic abortion
6 months before presenting with endocarditis,
but she had received appropriate antimicrobial
prophylaxis before the procedure. Recurrent
vaginalbleedingandaPapanicolaoucervicalsmear
performed 2 months prior to her admission could
have served as sources of GBS. Although no cases
with vaginal bleeding as the sole predisposing
factor were encountered in our literature search,
we believe that our patient’s recurrent episodes
of vaginal bleeding may well have enabled the
organism to invade her bloodstream, thereby
leadingtoinfectionofherprostheticheartvalves.
As in previous reports, treatment routinely
involved the use of a β-lactam antibiotic plus an
aminoglycoside for 4 to 6 weeks. The antibiotic of
choice for GBS endocarditis has been penicillin or
ampicillin19. Vancomycin is used in patients with
β-lactam allergy. Since the minimum inhibitory
concentration of penicillin for GBS is usually
four- to eight-fold higher than that for other
streptococci5,20, most authorities recommend the
additionofanaminoglycosideasasynergisticagent
to high doses of penicillin or ampicillin for at least
the first 2 weeks. The optimum duration of
treatment has not been established, but intra-
venous antibiotics are routinely given for 4 to
6 weeks. The role of chemoprophylaxis for
endocarditis in individuals with known valvular
heart disease outside the intrapartum setting has
not been well studied. Recommendations for
endocarditis prophylaxis from the American Heart
Association21 should be followed, but individual
decisions need to be made when dealing with
patients who have high-risk cardiac conditions, as
was illustrated by our patient.
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